Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 1
2008 2
2009 1
2011 1
2012 8
2013 5
2014 4
2015 2
2016 2
2017 5
2018 6
2019 2
2020 8
2021 9
2022 10
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal AM, Bennett AV, Thanarajasingam G, Rogak LJ, Reeve BB, Snyder C, Bruner D, Cella D, Kottschade LA, Perlmutter J, Geoghegan C, Samuel-Ryals CA, Given B, Mazza GL, Miller R, Strasser JF, Zylla DM, Weiss A, Blinder VS, Dueck AC. Basch E, et al. Among authors: blinder vs. JAMA. 2022 Jun 28;327(24):2413-2422. doi: 10.1001/jama.2022.9265. JAMA. 2022. PMID: 35661856 Free PMC article. Clinical Trial.
Impact of Cancer on Employment.
Blinder VS, Gany FM. Blinder VS, et al. J Clin Oncol. 2020 Feb 1;38(4):302-309. doi: 10.1200/JCO.19.01856. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804857 Free PMC article. Review. No abstract available.
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.
Tolaney SM, Garrett-Mayer E, White J, Blinder VS, Foster JC, Amiri-Kordestani L, Hwang ES, Bliss JM, Rakovitch E, Perlmutter J, Spears PA, Frank E, Tung NM, Elias AD, Cameron D, Denduluri N, Best AF, DiLeo A, Baizer L, Butler LP, Schwartz E, Winer EP, Korde LA. Tolaney SM, et al. Among authors: blinder vs. J Clin Oncol. 2021 Aug 20;39(24):2720-2731. doi: 10.1200/JCO.20.03613. Epub 2021 May 18. J Clin Oncol. 2021. PMID: 34003702 Free PMC article.
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araújo FS, Hlubocky FJ, Nicholas LH, O'Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella D. de Souza JA, et al. Among authors: blinder v. Cancer. 2017 Feb 1;123(3):476-484. doi: 10.1002/cncr.30369. Epub 2016 Oct 7. Cancer. 2017. PMID: 27716900 Free PMC article.
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Scott JM, Lee J, Herndon JE, Michalski MG, Lee CP, O'Brien KA, Sasso JP, Yu AF, Rowed KA, Bromberg JF, Traina TA, Gucalp A, Sanford RA, Gajria D, Modi S, Comen EA, D'Andrea G, Blinder VS, Eves ND, Peppercorn JM, Moskowitz CS, Dang CT, Jones LW. Scott JM, et al. Among authors: blinder vs. Eur Heart J. 2023 Dec 7;44(46):4878-4889. doi: 10.1093/eurheartj/ehad085. Eur Heart J. 2023. PMID: 36806405 Free PMC article. Clinical Trial.
Effects of patient-reported outcome assessment order.
Novotny PJ, Dueck AC, Satele D, Frost MH, Beebe TJ, Yost KJ, Lee MK, Eton DT, Yount S, Cella D, Mendoza TR, Cleeland CS, Blinder V, Basch E, Sloan JA. Novotny PJ, et al. Among authors: blinder v. Clin Trials. 2022 Jun;19(3):307-315. doi: 10.1177/17407745211073788. Epub 2022 Jan 28. Clin Trials. 2022. PMID: 35088616 Free PMC article. Clinical Trial.
Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
Blinder VS, Deal AM, Ginos B, Jansen J, Dueck AC, Mazza GL, Henson S, Carr P, Rogak LJ, Weiss A, Rapperport A, Jonsson M, Spears PA, Cella D, Gany F, Schrag D, Basch E. Blinder VS, et al. J Clin Oncol. 2023 Oct 10;41(29):4652-4663. doi: 10.1200/JCO.22.02834. Epub 2023 Aug 25. J Clin Oncol. 2023. PMID: 37625107 Clinical Trial.
63 results